American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 12(65), 2021
DOI: 10.1128/aac.01381-21
Full text: Download
Linezolid is widely used for drug-resistant tuberculosis (DR-TB) but has a narrow therapeutic index. To inform dose optimization, we aimed to characterize the population pharmacokinetics of linezolid in South African participants with DR-TB and explore the effect of covariates, including HIV coinfection, on drug exposure.